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Abstract Rho-kinase-dependent Ca2+ sensitization is an
essential process for contraction of mammalian vascular
smooth muscle but the information about its eVects in non-
mammalian vessels is scarce. We aimed to investigate,
using the Rho-kinase inhibitor hydroxyfasudil, the potential
role of the Rho-kinase pathway of Ca2+ sensitization in
depolarization- and agonist-mediated contraction of
chicken embryo (at day 19 of the 21 days of incubation)
femoral arteries. Contraction elicited by KCl (125 mM)
comprised two phases (phasic and tonic contraction), both
of which were abolished in the absence of extracellular
Ca2+. Hydroxyfasudil (10 M) left the initial phasic compo-
nent nearly intact but abolished the tonic component.
Hydroxyfasudil also induced a marked impairment of the
contractions elicited by phenylephrine (PE), the thrombox-
ane A2 mimetic U46619, and endothelin-1. In contrast,
inhibition of protein kinase C (PKC) by chelerythrine did
not aVect KCl- or PE-induced contractions, indicating lack
of participation of PKC-mediated Ca2+ sensitization. Incu-
bation under chronic hypoxia (15% O2 from day 0)
impaired embryonic growth but did not signiWcantly aVect
hydroxyfasudil-mediated relaxation. In summary, our Wnd-
ings are indicative of a role for Rho-kinase activity in depo-
larization- and agonist-induced force generation in chicken
embryo femoral arteries.
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Introduction
Rho-associated kinases, the immediate downstream targets
of RhoA, are highly conserved and ubiquitously expressed
serine–threonine protein kinases that are implicated in a
variety of physiological functions associated with changes
in the actin cytoskeleton, such as cell adhesion, motility,
migration, and contraction. Thereby, Rho-kinases contrib-
ute to the control of some of the most fundamental pro-
cesses of cell biology common to all eukaryotes, including
morphogenesis, polarity, cytokinesis, apoptosis, and cell
division (JaVe and Hall 2005; Noma et al. 2006; Riento and
Ridley  2003). In addition, Rho-kinases contribute to
changes in gene expression that lead to cell-cycle progres-
sion or diVerentiated cell responses (Riento and Ridley
2003).
In smooth muscle cells, phosphorylation of the regula-
tory myosin light chain (MLC) is required to initiate con-
traction. Calcium ions play a primary role in this process.
Excitatory agonists induce a rise in the intracellular-free
Ca2+ concentration through Ca2+ release from intracellular
stores (sarcoplasmic reticulum) as well as entry from the
extracellular space through Ca2+ channels. This results in
the activation of the Ca2+-calmodulin-dependent MLC
kinase (MLCK). MLCK phosphorylates the 20-kDa MLC,
leading to the initiation of contraction (Cogolludo et al.
2007; Ratz et al. 2005; Somlyo and Somlyo 2003; Webb
2003). In addition, agonists can induce Ca2+ sensitization, a
phenomenon in which sustained constriction occurs, inde-
pendent of ongoing increases in cytosolic Ca2+, due to
MLC phosphatase (MLCP) inhibition and the resulting
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persistence of MLC phosphorylation. Rho-kinase was dem-
onstrated to phosphorylate the 110-kDa myosin binding
subunit (MYPT1) of MLCP to inhibit its activity. In addi-
tion, Rho-kinase, as well as protein kinase C (PKC), was
shown to phosphorylate and activate a MLCP inhibitor
phosphoprotein, CPI-17, to induce Ca2+ sensitization
(Cogolludo et al. 2007; Ratz et al. 2005; Somlyo and Som-
lyo 2003; Webb 2003).
Several speciWc Rho-kinase inhibitors, such as Y-27632,
fasudil, and hydroxyfasudil, have been developed in the
past few years (Breitenlechner et al. 2003; Davies et al.
2000; Shimokawa and Rashid 2007). Their use has led to
the appreciation of the RhoA/Rho-kinase pathway as a key
regulator of smooth muscle contraction in numerous mam-
malian species (Gao et al. 2007; Kitazawa et al. 2003; Mita
et al.  2002; Shimokawa et al. 1999; Wardle et al. 2007).
Moreover, in animal and clinical studies, Rho-kinase-medi-
ated Ca2+ sensitization has been shown to be substantially
involved in the pathogenesis of vasospasm, arteriosclerosis,
hypertension, pulmonary hypertension, and ischemia/reper-
fusion injury (Shimokawa and Rashid 2007).
Despite its relevance in the mammal, the published
information about the eVects of Rho-kinase inhibition on
vascular smooth muscle reactivity in non-mammalian spe-
cies is scarce. The chicken embryo is a good model for
investigating developmental vascular biology (Ruijtenbeek
et al. 2002). Receptor-independent and -dependent contrac-
tion as well as endothelium-dependent and -independent
relaxation are present in the chicken vasculature as early as
15 days of incubation and undergo marked developmental
changes (Agren et al. 2008,  2009; Villamor et al. 2002,
2004). In addition, the normal pattern of development of
vascular function can be altered by exposure during incuba-
tion to insults such as chronic hypoxia, malnutrition, or
drugs (Ruijtenbeek et al. 2000,  2003b; Van der Sterren
et al. 2009; Zoer et al. 2009). In the present study we aimed
to investigate, using the Rho-kinase inhibitor hydroxyfasu-
dil, the potential role of the RhoA/Rho-kinase pathway of
Ca2+ sensitization in depolarization- and agonist-mediated
contraction of chicken embryo femoral arteries. We also
evaluated whether exposure to chronic hypoxia during
incubation aVected the vascular response to Rho-kinase
inhibition.
Methods
The experiments were in accordance with the Dutch law for
animal experimentation. Fertilized eggs from White Leg-
horn chickens (‘t Anker, Ochten, The Netherlands) were
incubated at 37.8°C, 45% humidity and rotated once an
hour over an angle of 90° (Incubator model 25HS, Masalles
Comercial, Spain). Control embryos were incubated under
normoxic conditions (21% O2, 0.03% CO2) and a group of
eggs was incubated under hypoxic conditions (15.0 § 0.3%
atmospheric O2, 0.03% CO2) from day 0. Hypoxia was
maintained by providing a constant Xow of N2 and com-
pressed air (3,000 and 4,500 ml/min, respectively) with a
Xow meter (AGA Gas BV, The Netherlands), as previously
described (Zoer et al., 2009). The O2 and CO2 concentra-
tions in the incubator were monitored with a DrDAQ O2
sensor (Pico Technology, UK) and an infrared CO2 ana-
lyzer (Beckman Instruments, Inc., Fullerton, CA, USA).
At day 19 of the 21-day incubation period non-internally
pipped chicken embryos were decapitated and femoral
arteries were isolated and stored in cold Krebs–Ringer
bicarbonate (KRB) buVer. Rings of 1.7–2 mm were made
and mounted between an isometric force transducer (Kistler
Morce DSC 6, Seattle, WA, USA) and a displacement
device in a myograph (model 610M, Danish Myotechnol-
ogy, Aarhus, Denmark) using two stainless steel wires
(diameter 40 m). During mounting and experimentation,
the KRB buVer was maintained at 39°C and aerated with
95% O2–5% CO2. Each artery was stretched to its individ-
ual optimal lumen diameter, i.e., the diameter at which it
developed the strongest contractile response to 62.5 mM
KCl, using a diameter-tension protocol as previously
described (Villamor et al. 2002, 2004).
EVects of Rho-kinase and PKC inhibition on chicken 
embryo femoral artery contraction
The eVect of the Rho-kinase inhibitor hydroxyfasudil
(10 M) on contractile responses was assessed by treating
arterial segments for 30 min before adding KCl (125 mM),
phenylephrine (PE, 10 nM to 0.1 mM), the PKC activator
12,13 phorboldibutyrate (PDBu, 1 nM–1 M), endothelin-1
(ET-1, 1 nM–0.3 M), or the thromboxane A2 mimetic
U46619 (10 nM–3 M). The eVect of the PKC inhibitor
chelerythrine (10 M) on contractile responses to KCl and
PE was assessed in a similar way. The eVects of combined
hydroxyfasudil (10 M) and chelerythrine (10 M) were
also studied. In another group of experiments, responses to
KCl, PE, and PDBu were studied in 0 Ca2+ EGTA (3 mM)
KRB buVer. All experiments involving KCl-induced con-
tractions were performed in the presence of the adrenocep-
tor blockers prazosin (1 M) and propanolol (0.1 M) to
antagonize any eVects of catecholamines released from
nerve terminals.
Relaxation responses to hydroxyfasudil
Femoral artery rings were contracted with KCl (125 mM in
the presence of prazosin and propanolol) or PE (10 M)
until a stable contraction was achieved. Rings were then
treated with increasing concentrations of hydroxyfasudilJ Comp Physiol B (2010) 180:427–435 429
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(1 nM to 10 M). Some experiments were performed in the
presence of the nitric oxide (NO) synthase (NOS) inhibitor
N-nitro-L-arginine methyl ester (L-NAME, 100 M), or
the soluble guanylate cyclase inhibitor ODQ (10 M).
Drugs and solutions
Krebs–Ringer bicarbonate contained (in mmol per liter):
NaCl, 118.5; KCl, 4.75; MgSO4·7H2O, 1.2; KH2PO4, 1.2;
NaHCO3, 25.0; CaCl2, 2.5; glucose, 5.5. Solutions contain-
ing diVerent concentrations of K+ were prepared by replac-
ing part of the NaCl by an equimolar amount of KCl.
U46619 was obtained from Cayman Chemical (Ann Arbor,
MI, USA), and ODQ was from Tocris (Ballwin, MO,
USA). All the other drugs were obtained from Sigma (St
Louis, MO, USA). All drugs were dissolved initially in dis-
tilled deionized water (except U46619 and ODQ, which
were dissolved in DMSO) to prepare adequate stock solu-
tions and further dilutions were made in deionized water.
Data analysis
Results are shown as mean (SD) of measurements in n ani-
mals. For clarity, results in the Wgures are shown as
mean § SE. Contractions are expressed in terms of active
wall tension (N/m), calculated as the force divided by twice
the length of the arterial segment. Relaxant responses are
expressed as the percentage of reduction of the contraction
induced by KCl or PE. The potency (expressed as
pD2 = ¡log EC50) and eYcacy (expressed as maximal
eVect: Emax) of agonists was determined for each artery by
Wtting individual concentration–response data to a non-lin-
ear sigmoidal regression curve and interpolating (Graphpad
Prism version 2.01; GraphPad Software Inc, San Diego,
CA, USA). DiVerences between mean values were assessed
by one-way ANOVA followed by Bonferroni post hoc t
test. Unpaired t tests were used if only two groups were
compared. DiVerences were considered signiWcant at a
P < 0.05. All analyses were performed using a commer-
cially available statistics package (GraphPad InStat version
3.00, GraphPad Software Inc, San Diego, CA, USA).
Results
KCl-induced contractions
The addition of 125 mM KCl to rings of chicken embryo
femoral artery induced a contraction that peaked rapidly
and transiently (phasic component) and was followed by a
slowly developing contraction (tonic component) that
reached a plateau after approximately 10–15 min (Fig. 1a).
The forces of the phasic and tonic components of contrac-
tion evoked by 125 mM KCl were 1.25 N/m (SD 0.34,
n = 22) and 1.83 N/m (SD 0.43), respectively.
As shown in Fig. 1b, c, in the absence of extracellular
Ca2+ the phasic component of KCl-induced contraction was
markedly reduced (0.23 N/m SD 0.178, n =4 ,  P < 0.001)
and the tonic component was completely abolished. The
presence of hydroxyfasudil (10 M) did not signiWcantly
Fig. 1 a Typical tracing show-
ing the phasic and tonic compo-
nents of the contractile response 
of chicken embryo femoral 
artery to KCl (125 mM). 
b, c EVects (mean + SE) of 
elimination of extracellular Ca2+ 
(0 Ca + 3 mM EGTA), the 
Rho-kinase inhibitor hydroxy-
fasudil (10 M), the PKC 
inhibitor chelerythrine (10 M), 
and the combination of hydroxy-
fasudil and chelerythrine in the 
phasic (b) and the tonic (c) 
components of KCl-induced 
contraction. *P <0 . 0 5  
vs control
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aVect KCl-evoked phasic contraction (0.91 N/m, SD 0.23,
n = 6) but markedly impaired the tonic component (0.22 N/m,
SD 0.11, P < 0.001). Chelerythrine (10 M) did not
signiWcantly aVect either the phasic (1.36 N/m, SD 0.49,
n = 9) or the tonic (1.67 N/m, SD 0.76) contraction. The
combination of hydroxyfasudil and chelerythrine did not
induce a diVerent eVect on KCl-evoked contraction (phasic:
1.15 N/m, SD 0.31; tonic: 0.13 N/m, SD 0.04, n =8 )  t h a n
hydroxyfasudil alone.
PE-, U46619-, and ET-1-induced contractions
The  1-adrenegic receptor agonist PE induced concentra-
tion-dependent contractions with a mean maximal eVect
of 2.05 N/m (SD 0.58, n = 15) and a pD2 of 5.90 (SD
0.32). The absence of Ca2+ signiWcantly reduced the
eYcacy (Emax: 0.41, SD 0.22, n =6 ,   P < 0.001 vs control)
and the potency (pD2: 4.22, SD 0.49, P <0 . 0 1  v s  c o n t r o l )
of PE to contract the chicken embryo femoral artery
(Fig. 2). In the presence of hydroxyfasudil (10 M) the
eYcacy (Emax: 0.91 N/m, SD 0.44, n = 6, P < 0.01) but not
the potency (pD2: 5.34, SD 0.27) of PE was signiWcantly
reduced. In contrast, the PKC-inhibitor chelerythrine did
not signiWcantly aVect contractions to PE (Emax: 2.19 N/m
SD 0.39; pD2: 5.62, SD 0.32, n = 12). The combination of
hydroxyfasudil and chelerythrine did not induce a diVer-
ent eVect on PE-evoked contractions (Emax: 0.92 N/m SD
0.32,  n =8 ;  p D 2: 5.01, SD 0.24) than hydroxyfasudil
alone.
As shown in Fig. 2b, c, the contractions induced by
U46619 and ET-1 were markedly impaired in the presence
of hydroxyfasudil (10 M).
PDBu-induced contractions
As shown in Fig. 3a, the PKC activator PDBu induced a
concentration-dependent contraction in the chicken embryo
femoral arteries. In contrast, PDBu concentrations >0.1 M
induced relaxation. The mean maximal contraction induced
by PDBu was 1.04 N/m (SD 0.86, n = 18) with a pD2 of
7.62 (SD 0.30). In the absence of extracellular Ca2+ these
contractions were reduced to 0.25 N/m, SD 0.10, n =6
(P < 0.04 vs control) with a pD2 of 7.29, SD 0.07 (P <0 . 0 2
vs control). The presence of hydroxyfasudil impaired the
potency (pD2: 7.15 SD 0.39, n =9 ,   P < 0.02 vs control) but
not the eYcacy (Emax: 0.52 N/m, SD 0.47) of PDBu to con-
tract chicken embryo femoral arteries.
Hydroxyfasudil-induced relaxation
In chicken embryo femoral arteries contracted with KCl
(125 mM, active wall tension: 1.82 N/m, SD 0.34, n = 23)
Fig. 2 a EVects (mean + SE) of elimination of extracellular Ca2+
(0 Ca + 3 mM EGTA), the Rho-kinase inhibitor hydroxyfasudil
(10 M), the PKC inhibitor chelerythrine (10 M), and the combina-
tion of hydroxyfasudil and chelerythrine on the concentration-depen-
dent contraction induced by phenylephrine in chicken embryo femoral
arteries. b, c EVects of hydroxyfasudil (10 M) on the contractions
induced by endothelin-1 (b) and the thromboxane A2 mimetic U46619
(c). *P < 0.05 for diVerence in Emax from control. #P < 0.05 for diVer-
ence in pD2 from control
A
-8 -7 -6 -5 -4
0.0
0.5
1.0
1.5
2.0
2.5
chele
chele + OH-fasu
OH-fasu
control
*
*
0 Ca EGTA
* #
log[PE](M)
A
c
t
i
v
e
 
w
a
l
l
 
t
e
n
s
i
o
n
 
(
N
/
m
)
B
-10 -9 -8 -7
0.0
0.5
1.0
1.5
2.0
control
OH-fasu
*
log[ET-1](M)
A
c
t
i
v
e
 
w
a
l
l
 
t
e
n
s
i
o
n
 
(
N
/
m
)
-8 -7 -6 -5
0.0
0.5
1.0
1.5
2.0
control
OH-fasu
*
log[U46619](M)
A
c
t
i
v
e
 
w
a
l
l
 
t
e
n
s
i
o
n
 
(
N
/
m
)
CJ Comp Physiol B (2010) 180:427–435 431
123
or PE (10 M, active wall tension: 2.18 N/m, SD 0.59,
n = 12), hydroxyfasudil induced concentration-dependent
relaxations (KCl: 97.18%, SD 5.57; PE: 96.07%, SD 6.66)
with pD2 values of, respectively, 5.96 (SD 0.28) and 5.75
(SD 0.30) that were not signiWcantly diVerent (Fig. 4a).
Hydroxyfasudil-induced relaxation of KCl-contracted
arteries was signiWcantly impaired by the presence of the
NOS inhibitor L-NAME (Emax: 88.51%, SD 5.73; pD2:
5.70, SD 0.08, n =8 , P < 0.05 vs control) but not by the
presence of the soluble guanylate cyclase inhibitor ODQ
(Emax: 94.28%, SD 4.92; pD2: 5.88, SD 0.25, n =5 )
(Fig. 4a).
EVects of chronic hypoxia
Incubation under chronic hypoxia reduced embryonic body
mass (23.7 g, SD 0.6, n = 49 vs 28.3 g, SD 0.4, n =2 0 ,
P < 0.001) but did not signiWcantly aVect the contraction
induced by KCl (2.08 N/m, SD 0.69, n = 17) or PE (2.35 N/m,
SD 1.02, n = 13) in chicken embryo femoral arteries. As
shown in Fig. 4b, c, chronic hypoxia did not signiWcantly
aVect hydroxyfasudil-induced relaxation of KCl- (Emax:
99.01%, SD 16.05; pD2: 6.12, SD 0.70), or PE-contracted
arteries (Emax: 101.20%, SD 10.03; pD2: 6.41, SD 0.95).
Fig. 3 a Typical tracing showing the eVects of cumulative concentra-
tions of the PKC activator 12,13 phorboldibutyrate (PDBu) in the
chicken embryo femoral artery. b EVects (mean + SE) of elimination
of extracellular Ca2+ (0 Ca + 3 mM EGTA), and the Rho-kinase inhib-
itor hydroxyfasudil (10 M) on PDBu-induced contractions.
*P < 0.05 for diVerence in Emax from control. #P < 0.05 for diVerence
in pD2 from control
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Discussion
Ca2+ sensitization in smooth muscle involves multiple cell
signaling strategies, including activation of Rho-kinase and
PKC. In the present study, we found that treatment with the
selective inhibitor of Rho-kinase hydroxyfasudil com-
pletely relaxed chicken embryo femoral artery rings con-
tracted with KCl or PE. Also the contractions induced by
the thromboxane A2 mimetic U46619 and ET-1 were
reduced in the presence of hydroxyfasudil. Our Wndings are
indicative of a role for Rho-kinase activity in depolariza-
tion- and agonist-induced force generation in chicken
embryo femoral arteries. In contrast, inhibition of PKC by
chelerythrine did not aVect KCl- or PE-induced contrac-
tions, indicating a lack of participation of PKC-mediated
Ca2+ sensitization.
Chicken embryo femoral artery contraction elicited by
KCl comprises two phases (phasic and tonic contraction),
both of which are dependent on inXux of extracellular Ca2+.
In contrast, Rho-kinase inhibition left the initial phasic
component nearly intact but abolished the tonic component.
KCl-induced contraction has long been known to be due to
membrane depolarization causing Ca2+ entry through volt-
age-operated Ca2+ channels, activation of Ca2+-dependent
MLCK, and increase in MLC phosphorylation (Ratz et al.
2005). However, in the past few years numerous experi-
mental evidences indicate that, by increasing intracellular
Ca2+ concentration, KCl has the potential to act as a stimu-
lus to change the degree of Ca2+ sensitivity in mammalian
vessels (Buyukafsar et al. 2006; Kupittayanant et al. 2001;
Mita et al. 2002; Ratz et al. 2005; Sakamoto et al. 2003;
Sakurada et al. 2003). The mechanisms by which high
extracellular K+ induces Ca2+ sensitization is not yet fully
understood but appears to involve translocation and activa-
tion of Rho-kinase (Ratz et al. 2005). In fact, Rho-kinase
inhibitors such as Y-27632, fasudil, or hydroxyfasudil
inhibited KCl-induced contraction of most smooth muscle
types in many mammalian species, including human (Buyu-
kafsar et al. 2006; Kupittayanant et al. 2001), rat (Mita et al.
2002; Sakamoto et al. 2003), rabbit (Sakurada et al. 2003),
mouse (Ayman et al. 2003), pig (Janssen et al. 2004), cow
(Janssen et al. 2004), and sheep (Levent and Buyukafsar
2004). Our present results suggest that KCl-evoked contrac-
tion also involves Rho-kinase-mediated Ca2+ sensitization
in chicken embryo vascular smooth muscle.
As mentioned above, the published information about
the eVects of Rho-kinase inhibition on vascular smooth
muscle reactivity in non-mammalian species is scarce. In
the chicken embryo ductus arteriosus, hydroxyfasudil and
Y-27632 impaired the contractions induced by KCl, oxy-
gen, 4-aminopyridine, PE, and ET-1 (Cogolludo et al.
2009; Greyner and Dzialowski 2008; Van der Sterren et al.
2009; Villamor et al. 2008). Interestingly, the Wrst smooth
muscle in which Rho-kinase was isolated and characterized
was the chicken gizzard (Feng et al. 1999b). Chicken giz-
zard has been widely used as a source of smooth muscle
contractile proteins for biochemical study and its smooth
muscle is classiWed as a typical phasic-type muscle because
it shows only a transient contraction with no sustained
phase in response to KCl or G-protein coupled receptor
agonists (Anabuki et al. 2000). Anabuki et al. (2000)
observed that chicken gizzard phasic contraction was not
aVected by the presence of the Rho-kinase inhibitor
Y27632. Moreover, when Ca2+ sensitization was tested
through the eVect of stimulation of small G-proteins by the
unhydrolyzable analog of GTP GTPS, it was found that
the degree of Ca2+ sensitization was less in chicken gizzard
than in chicken cranial tibial artery. This suggests that Rho-
kinase-induced Ca2+ sensitization might be of a lesser rele-
vance in the phasic-type gizzard smooth muscle than in the
tonic-type vascular smooth muscle (Anabuki et al. 2000).
In smooth muscle cells, Rho-kinase increases MLC
phosphorylation through inhibiting MLCP activity, which
leads to contraction. The speciWc mechanism responsible
for MLCP inhibition appears to be species, tissue, and ago-
nist dependent (El-Toukhy et al. 2006). MLCP is a trimeric
protein consisting of three subunits: a myosin-binding sub-
unit (MYPT1), a catalytic subunit (PP1c), and a 20-kDa
subunit of an unknown function. Two mechanisms for
MLCP inhibition are widely accepted: (1) the phosphoryla-
tion of MYPT1, and (2) the binding of phosphatase inhibi-
tor proteins, such as CPI-17 or the phosphoprotein
holoenzyme inhibitor-1 (PHI-1), to the catalytic subunit of
the enzyme (El-Toukhy et al. 2006; Ratz et al. 2005; Som-
lyo and Somlyo 2003; Webb 2003). Rho-kinase has been
demonstrated to phosphorylate MYPT1 at Thr695 in the
avian (Feng et al. 1999a), or Thr697 in the mammalian
sequence (Somlyo and Somlyo 2003). However, El-Tou-
khy et al. (2005) demonstrated that phosphorylation of
MYPT1 does not participate in Ca2+ sensitization of
chicken smooth muscle tissue. An alternative mechanism
for Ca2+ sensitization would be a Rho-kinase or PKC-medi-
ated phosphorylation of CPI-17. However, CPI-17 was
undetectable in chicken smooth muscle (aorta, mesenteric
artery, gizzard, and small intestine) (Kitazawa et al. 2004).
This raises the possibility that another phosphatase inhibi-
tor protein mediates Ca2+ sensitization in chicken smooth
muscle. Accordingly, El-Toukhy et al. (2006) demonstrated
that in chicken gizzard smooth muscle a Rho-kinase-medi-
ated pathway induced an increase in PHI-1 phosphorylation
and contractile force.
The absence of CPI-17 in chicken smooth muscles
presented a useful model system for studying the role of
phosphatase inhibitor proteins in Ca2+ sensitization. In the
study of Kitazawa et al., the absence of CPI-17 in adult
chicken aorta and mesenteric arteries correlated with a lackJ Comp Physiol B (2010) 180:427–435 433
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of PKC-dependent Ca2+ sensitization (Kitazawa et al.
2004). Moreover, they observed that PDBu-mediated PKC
activation did not evoke signiWcant contraction in either
intact or permeabilized adult chicken mesenteric arteries
(Kitazawa et al. 2004). In contrast, we observed that in
chicken embryo femoral arteries PDBu induced a signiW-
cant contraction, which was completely dependent on
inXux of extracellular Ca2+ and partially inhibited in the
presence of hydroxyfasudil. However, neither KCl- nor
PE-induced contraction were aVected by the PKC inhibitor
chelerythrine. Our data, therefore, suggest that PKC activa-
tion does not mediate the contractile responses induced by
KCl or PE in chicken embryo femoral arteries but also that
direct PKC activation is capable of developing a contrac-
tion in these vessels. Ca2+ sensitization is not the only path-
way by which PKC induces contraction and other signaling
proteins implicated, such as mitogen-activated protein
kinases (MAPKs), are expressed in chicken smooth mus-
cles (Kitazawa et al. 2004). Developmental changes in the
signaling pathways that mediate PKC-induced contraction
have been described in mammalian vessels. In ovine cere-
bral arteries, PDBu induced Ca2+-dependent contraction in
fetal animals and Ca2+-independent contraction in the adult
(Longo et al. 2000). This suggests that in fetal cerebral
arteries, PKC-induced contraction is more coupled to Ca2+
Xux than to Ca2+ sensitivity mechanisms. Whether these
developmental changes are also present in chicken vessels
warrants further investigation.
Besides its profound eVects on smooth muscle cells,
Rho-kinase is also involved in the regulation of endothelial
NO synthase (eNOS) in mammalian vessels (Bussemaker
et al.  2007; Ming et al. 2002). Rho-kinase can directly
inhibit eNOS (Sugimoto et al. 2007) and incubation of
human endothelial cells with hydroxyfasudil resulted in
increased NO production (Wolfrum et al. 2004). Further-
more, inhibition of Rho-kinase by hydroxyfasudil and
Y27632, or by overexpression of a dominant-negative
mutant of Rho-kinase, increases eNOS mRNA half-life and
expression (Rikitake et al. 2005). In chicken embryo femo-
ral arteries we observed that the blockade of NOS with
L-NAME produced a slight but signiWcant attenuation of
hydroxyfasudil-induced relaxation. This suggests that in
chicken embryo femoral arteries a very small portion of the
relaxation induced by Rho-kinase inhibition is mediated by
NO and that vascular bioavailable NO might be partly regu-
lated by Rho-kinase.
Numerous studies have shown that chronic hypoxia
decreases the growth of developing chicken embryos (Been
et al. 2009; Dzialowski et al. 2002; Giussani et al. 2007;
Ruijtenbeek et al. 2003b; Villamor et al. 2004; Zoer et al.
2009) and induces a broad spectrum of structural and func-
tional vascular alterations (Ruijtenbeek et al. 2000, 2003a,
b; Van der Sterren et al. 2009; Villamor et al. 2004). As
reported elsewhere, chronic moderate hypoxia in the
chicken embryo led, in the femoral artery, to impairment of
endothelium-dependent relaxation (Ruijtenbeek et al.
2003b; Villamor et al. 2004) and increased periarterial
sympathetic innervation (Ruijtenbeek et al. 2000) Experi-
mental evidences indicate that chronic hypoxia augments
Rho-kinase-induced vascular smooth muscle Ca2+ sensiti-
zation in mammalian vessels (Bailly et al. 2004; Jernigan
et al. 2004; McNamara et al. 2008; Oka et al. 2007). In the
present study, we observed that hypoxia-induced growth
retardation was not accompanied by signiWcant changes in
the potency or eYcacy of hydroxyfasudil to relax chicken
embryo femoral arteries. Previously, we demonstrated that
the relaxation evoked by Y-27632 and hydroxyfasudil was
similar in the ductus arteriosus from normoxic and hypoxic
chicken embryos (Van der Sterren et al. 2009). These data
indirectly suggest that Rho-kinase activity in the chicken
embryo vasculature is unaVected by chronic prenatal
hypoxia.
Approximately 1% of the human genome encodes pro-
teins that either regulate or are regulated by direct interac-
tion with members of the Rho family of small GTPases.
Through a series of complex biochemical networks, these
highly conserved molecular switches control some of the
most fundamental processes of cell biology (JaVe and Hall
2005). Our present results provide the Wrst functional evi-
dence for a role of the Rho-kinase pathway of Ca2+ sensiti-
zation in depolarization- and agonist-mediated contraction
of chicken embryo arteries. They warrant further investiga-
tion through simultaneous measurement of intracellular
Ca2+ and contractile force, as well as determination of
developmental changes on the expression of key proteins
involved in Ca2+ sensitization.
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